3.0.0 3276 2023-01-11T13:16:47Z 2023-01-11T13:16:47Z House H HR 2009-07-21 111 sseg00 Energy and Natural Resources Committee Senate Standing Reported by 2010-01-28T18:02:16Z Markup by 2009-12-16T16:34:32Z Hearings by 2009-12-03T16:11:58Z Referred to 2009-11-06T16:36:13Z hsif00 Energy and Commerce Committee House Standing hsif03 Energy, Climate and Grid Security Subcommittee Reported by 2009-10-14T17:28:52Z Markup by 2009-10-14T17:28:17Z Hearings by 2009-09-09T21:34:19Z Referred to 2009-07-22T21:34:04Z hsif14 Health Subcommittee Referred to 2009-07-21T15:23:19Z Reported by 2009-11-04T22:31:54Z Markup by 2009-10-21T14:13:54Z Referred to 2009-07-21T14:31:48Z S. Rept. 111-120 H. Rept. 111-328 2010-01-28 Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 263. Calendars 2010-01-28 sseg00 Energy and Natural Resources Committee Senate Committee on Energy and Natural Resources. Reported by Senator Bingaman with amendments. With written report No. 111-120. Committee 2010-01-28 Committee on Energy and Natural Resources. Reported by Senator Bingaman with amendments. With written report No. 111-120. Committee 14000 9 Library of Congress sseg00 Energy and Natural Resources Committee 2009-12-16 sseg00 Energy and Natural Resources Committee Senate Committee on Energy and Natural Resources. Ordered to be reported with an amendment in the nature of a substitute favorably. Committee 2009-12-03 sseg00 Energy and Natural Resources Committee Senate Committee on Energy and Natural Resources. Hearings held. Committee 2009-11-06 sseg00 Energy and Natural Resources Committee Senate Received in the Senate and Read twice and referred to the Committee on Energy and Natural Resources. IntroReferral 2009-11-05 17:49:47 Motion to reconsider laid on the table Agreed to without objection. Floor H38310 2 House floor actions 2009-11-05 17:49:46 On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 400 - 17 (Roll no. 863). (text: CR H12401-12403) Floor H37300 2 House floor actions 863 https://clerk.house.gov/evs/2009/roll863.xml House 111 2009-11-05T22:49:46Z 1 2009-11-05 17:49:46 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 400 - 17 (Roll no. 863).(text: CR H12401-12403) Floor 8000 9 Library of Congress 863 https://clerk.house.gov/evs/2009/roll863.xml House 111 2009-11-05T22:49:46Z 1 2009-11-05 17:41:16 Considered as unfinished business. (consideration: CR H12426-12427) Floor H30000 2 House floor actions 2009-11-05 15:23:10 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. Floor H37220 2 House floor actions 2009-11-05 15:09:48 DEBATE - The House proceeded with forty minutes of debate on H.R. 3276. Floor H8D000 2 House floor actions 2009-11-05 15:09:47 Considered under suspension of the rules. (consideration: CR H12401-12406) Floor H30000 2 House floor actions 2009-11-05 15:09:45 Mr. Markey (MA) moved to suspend the rules and pass the bill, as amended. Floor H30300 2 House floor actions 2009-11-04 Placed on the Union Calendar, Calendar No. 187. Calendars H12410 2 House floor actions U00187 2009-11-04 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-328. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2009-11-04 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-328. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2009-10-21 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2009-10-21 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2009-10-14 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . Committee 2009-10-14 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2009-09-09 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Subcommittee Hearings Held. Committee 2009-07-22 hsif03 Energy, Climate and Grid Security Subcommittee 1 House committee actions Referred to the Subcommittee on Energy and Environment. Committee 2009-07-21 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2009-07-21 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2009-07-21 Introduced in House IntroReferral Intro-H 9 Library of Congress 2009-07-21 Introduced in House IntroReferral 1000 9 Library of Congress M000133 Rep. Markey, Edward J. [D-MA-7] Edward Markey D MA J. 7 N U000031 Rep. Upton, Fred [R-MI-6] FRED UPTON R MI 6 2009-07-21 True C001060 Rep. Carnahan, Russ [D-MO-3] Russ Carnahan D MO 3 2009-07-31 False M000312 Rep. McGovern, James P. [D-MA-3] JAMES MCGOVERN D MA P. 3 2009-09-25 False B000575 Rep. Blunt, Roy [R-MO-7] ROY BLUNT R MO 7 2009-10-15 False I000026 Rep. Inslee, Jay [D-WA-1] JAY INSLEE D WA 1 2009-10-20 False S001174 Rep. Sutton, Betty [D-OH-13] Betty Sutton D OH 13 2009-11-02 False L000397 Rep. Lofgren, Zoe [D-CA-16] ZOE LOFGREN D CA 16 2009-11-02 False 2009-10-27T04:00:00Z H.R. 3276, American Medical Isotopes Production Act of 2009 http://www.cbo.gov/publication/41376 <p>Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on October 21, 2009</p> 2009-10-27T04:00:00Z H.R. 3276, American Medical Isotopes Production Act of 2009 https://www.cbo.gov/publication/41376 Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on October 21, 2009 2010-01-13T17:00:00Z H.R. 3276, American Medical Isotopes Production Act of 2009 http://www.cbo.gov/publication/41912 <p>Cost estimate for the bill as ordered reported by the Senate Committee on Energy and Natural Resources on December 16, 2009</p> 2010-01-13T17:00:00Z H.R. 3276, American Medical Isotopes Production Act of 2009 https://www.cbo.gov/publication/41912 Cost estimate for the bill as ordered reported by the Senate Committee on Energy and Natural Resources on December 16, 2009 Energy Arms control and nonproliferation Congressional oversight Government studies and investigations Hazardous wastes and toxic substances Health technology, devices, supplies Licensing and registrations Manufacturing Medical tests and diagnostic methods Nuclear power Nuclear weapons Public contracts and procurement Radioactive wastes and releases Trade restrictions Energy 00 2009-07-21 Introduced in House 2009-07-28T21:08:11Z American Medical Isotopes Production Act of 2009 - Directs the Secretary of Energy to establish a program to evaluate and support projects for the production in the United States, without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses.

Directs the Secretary also to establish a program to provide assistance for: (1) the development of fuels, targets, and processes for domestic molybdenum-99 production that do not use highly enriched uranium; and (2) commercial operations using such fuels, targets, and processes.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for the production of molybdenum-99 for medical uses.

Amends the Atomic Energy Act of 1954 to: (1) prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States, beginning seven years after enactment of this Act; and (2) authorize an extension of the seven-year period for up to another three years if the Secretary makes specified certifications to appropriate congressional committees.

Requires the NRC Chairman to report to Congress on the current disposition of previous U.S. exports of highly enriched uranium.

Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if, in addition to other requirements, certain conditions are met.

Directs the Secretary to arrange with the National Academy of Sciences (NAS) to study and report to Congress on the state of molybdenum-99 production and utilization.

]]> 17 2009-11-04 Reported to House with amendment(s) 2010-02-03T20:23:16Z American Medical Isotopes Production Act of 2009 - (Sec. 3) Directs the Secretary of Energy to establish a program to evaluate and support projects for the production in the United States (domestic production), without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses.

States that an existing reactor fueled with highly enriched uranium shall not be disqualified from the program if the Secretary makes specified determinations.

Authorizes appropriations to implement the program for FY2010-FY2014.

Directs the Secretary also to establish a program to provide assistance for: (1) the development of fuels, targets, and processes for domestic molybdenum-99 production that do not use highly enriched uranium; and (2) commercial operations using such fuels, targets, and processes.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Requires lease contracts to retain in the Secretary responsibility for the final disposition of radioactive waste created by irradiation, processing, or purification of leased uranium.

(Sec. 4) Amends the Atomic Energy Act of 1954 to prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States for medical isotope production purposes, beginning seven years after enactment of this Act.

Authorizes an extension of the seven-year period for up to another four years if the Secretary certifies to certain congressional committees that: (1) there is insufficient global supply of molybdenum-99 produced without the use of highly enriched uranium available to satisfy the domestic U.S. market; and (2) the export of United States-origin highly enriched uranium for the purposes of medical isotope production is the most effective temporary means to increase the supply of molybdenum-99 to such market.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic medical isotope needs; (2) the Secretary certifies to Congress that the export of domestic-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet domestic medical isotope needs during that period; and (3) Congress passes a joint resolution approving the temporary suspension of such export license restriction.

(Sec. 5) Requires the NRC Chairman to report to Congress on the current disposition of previous U.S. exports of highly enriched uranium.

(Sec. 6) Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if certain conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

(Sec. 7) Directs the Secretary to report to Congress annually for five years on Department of Energy (DOE) actions to support domestic production of molybdenum-99 for medical uses without the use of highly enriched uranium.

(Sec. 8) Directs the Secretary to arrange with the National Academy of Sciences (NAS) to study and report to Congress on the state of molybdenum-99 production and utilization. Requires the study to assess: (1) progress made in the previous five years toward establishing domestic production of molybdenum-99 for medical uses, including the extent to which other medical isotopes coproduced with molybdenum-99, such as iodine-131 and xenon-133, are being used for such purposes; as well as (2) progress made by DOE and others to eliminate all worldwide use of highly enriched uranium in reactor fuel, reactor targets, and medical isotope production facilities.

]]> 36 2009-11-05 Passed House amended 2010-02-03T20:21:35Z (This measure has not been amended since it was reported to the House on November 4, 2009. The summary of that version is repeated here.)

American Medical Isotopes Production Act of 2009 - (Sec. 3) Directs the Secretary of Energy to establish a program to evaluate and support projects for the production in the United States (domestic production), without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses.

States that an existing reactor fueled with highly enriched uranium shall not be disqualified from the program if the Secretary makes specified determinations.

Authorizes appropriations to implement the program for FY2010-FY2014.

Directs the Secretary also to establish a program to provide assistance for: (1) the development of fuels, targets, and processes for domestic molybdenum-99 production that do not use highly enriched uranium; and (2) commercial operations using such fuels, targets, and processes.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Requires lease contracts to retain in the Secretary responsibility for the final disposition of radioactive waste created by irradiation, processing, or purification of leased uranium.

(Sec. 4) Amends the Atomic Energy Act of 1954 to prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States for medical isotope production purposes, beginning seven years after enactment of this Act.

Authorizes an extension of the seven-year period for up to another four years if the Secretary certifies to certain congressional committees that: (1) there is insufficient global supply of molybdenum-99 produced without the use of highly enriched uranium available to satisfy the domestic U.S. market; and (2) the export of United States-origin highly enriched uranium for the purposes of medical isotope production is the most effective temporary means to increase the supply of molybdenum-99 to such market.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic medical isotope needs; (2) the Secretary certifies to Congress that the export of domestic-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet domestic medical isotope needs during that period; and (3) Congress passes a joint resolution approving the temporary suspension of such export license restriction.

(Sec. 5) Requires the NRC Chairman to report to Congress on the current disposition of previous U.S. exports of highly enriched uranium.

(Sec. 6) Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if certain conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

(Sec. 7) Directs the Secretary to report to Congress annually for five years on Department of Energy (DOE) actions to support domestic production of molybdenum-99 for medical uses without the use of highly enriched uranium.

(Sec. 8) Directs the Secretary to arrange with the National Academy of Sciences (NAS) to study and report to Congress on the state of molybdenum-99 production and utilization. Requires the study to assess: (1) progress made in the previous five years toward establishing domestic production of molybdenum-99 for medical uses, including the extent to which other medical isotopes coproduced with molybdenum-99, such as iodine-131 and xenon-133, are being used for such purposes; as well as (2) progress made by DOE and others to eliminate all worldwide use of highly enriched uranium in reactor fuel, reactor targets, and medical isotope production facilities.

]]> 01 2010-01-28 Reported to Senate with amendment(s) 2011-03-24T15:11:22Z American Medical Isotopes Production Act of 2010 - (Sec. 2) Directs the Secretary of Energy to establish a technology-neutral program to evaluate and support projects for the production in the United States (domestic production), without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses, implemented in cooperation with non-federal entities, the costs of which shall be shared in accordance with certain cost sharing requirements of the Energy Policy Act of 2005.

States that an existing reactor fueled with highly enriched uranium shall not be disqualified from the program if the Secretary makes specified determinations.

Instructs the Secretary to: (1) develop a program plan and update it annually through public workshops; and (2) use the Nuclear Science Advisory Committee to conduct annual reviews of the progress made in achieving program goals.

Authorizes appropriations for FY2010-FY2014 to implement the program.

Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses.

Requires lease contracts to retain in the Secretary responsibility for the final disposition of radioactive waste created by irradiation, processing, or purification of leased uranium.

(Sec. 3) Amends the Atomic Energy Act of 1954 to prohibit the Nuclear Regulatory Commission (NRC), beginning seven years after enactment of this Act, from issuing a license for the export of highly enriched uranium from the United States for medical isotope production purposes.

Authorizes an extension of the seven-year period for up to another six years if the Secretary certifies to certain congressional committees that: (1) there is insufficient global supply of molybdenum-99 produced without the use of highly enriched uranium available to satisfy the domestic US market; and (2) the export of United States-origin highly enriched uranium for the purposes of medical isotope production is the most effective temporary means to increase the supply of molybdenum-99 to such market.

Requires development of such certification to be carried out through announcement in the Federal Register in order to ensure public review and comment.

Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of molybdenum-99 to satisfy domestic medical isotope needs; (2) the Secretary certifies to Congress that the export of domestic-origin highly enriched uranium for medical isotope production is the only effective temporary means to increase the supply of molybdenum-99 necessary to meet domestic medical isotope needs during that period; and (3) Congress enacts a joint resolution approving the temporary suspension of such export license restriction.

(Sec. 4) Requires the NRC Chairman to report to Congress on the current disposition of previous U.S. exports of highly enriched uranium.

(Sec. 5) Amends the Atomic Energy Act of 1954 to authorize the NRC to issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if specified conditions are met, including certification by the Secretary that the federal government is actively supporting development of an alternative medical isotope production target that can be used in that reactor.

(Sec. 6) Directs the Secretary to report to Congress annually for five years on Department of Energy (DOE) actions to support domestic production of molybdenum-99 for medical uses without the use of highly enriched uranium.

(Sec. 7) Directs the Secretary to arrange with the National Academy of Sciences (NAS) to study and report to Congress on the state of molybdenum-99 production and utilization. Requires such study to assess: (1) progress made in the previous five years toward establishing domestic production of molybdenum-99 for medical uses, including the extent to which other medical isotopes that have been produced with molybdenum-99, such as iodine-131 and xenon-133, are being used for such purposes; and (2) the progress made by DOE and others to eliminate all worldwide use of highly enriched uranium in reactor fuel, reactor targets, and medical isotope production facilities.

]]> American Medical Isotopes Production Act of 2010 Display Title American Medical Isotopes Production Act of 2010 Official Title as Introduced To promote the production of molybdenum-99 in the United States for medical isotope production, and to condition and phase out the export of highly enriched uranium for the production of medical isotopes. Introduced in House IH Short Titles as Introduced American Medical Isotopes Production Act of 2009 Short Titles as Reported to House American Medical Isotopes Production Act of 2009 H House Short Titles as Reported to Senate American Medical Isotopes Production Act of 2010 S Senate Short Titles as Passed House American Medical Isotopes Production Act of 2009 H House Reported to Senate 2010-01-28T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr3276rs/xml/BILLS-111hr3276rs.xml Referred in Senate 2009-11-06T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr3276rfs/xml/BILLS-111hr3276rfs.xml Engrossed in House 2009-11-05T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr3276eh/xml/BILLS-111hr3276eh.xml Reported in House 2009-11-04T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr3276rh/xml/BILLS-111hr3276rh.xml Introduced in House 2009-07-21T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-111hr3276ih/xml/BILLS-111hr3276ih.xml 2010-01-28 Placed on Senate Legislative Calendar under General Orders. Calendar No. 263. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.